Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-flow Low-gradient Aortic Stenosis – Ivabradine vs Dobutamine
2016-002015-17Phase 3Terminated
- Sponsor
- University Hospital Odense
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ivabradine in aortic stenosis (AS), sponsored by University Hospital Odense. Primary endpoint: Primary endpoint: change in heart rate. Started Sep 2016; status: terminated.
02
Drugs
ivabradine
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2016-002015-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002015-17.